Some lower BMI patients have underlying insulin resistance, prediabetes, or metabolic dysfunction that benefits from GLP-1 receptor activation independent of weight loss
[DOI] [PubMed] [Google Scholar] 74.Boullata JI, Nace AM
IH NMR (D20): 8.55 (s, IH), 7.5 (d, 2H), 6.6 (d, 2H), 4.4 (s, 2H), 4.25 (m,2H), 4.1 (m, 5H), 3.85 (t, IH), 3.8-3.4 (m, 21H), 3.4-2.95 (m, 7H), 2.8 (s, 2H), 2.7-2.4 (ddd, 2H), 2.4-1.7 (m, 22H), 1.55 (m, IH)
Sample questions that have been used include: How hard is it for you to pay for the very basics like food, housing, medical care, and heating
Deep analysis: The study examined the 12 months following a first prescription of semaglutide compared to sitagliptin, empagliflozin, and glipizide in patients with type 2 diabetes, evaluating more than 19,000 records for each group.